CLSD   $0.41  -26.96% Market Open

Clearside Biomedical, Inc.
Last Events:

2023-08-09 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-06 Trend pattern changed from сужающийся канал to нисходящий треугольник.

2023-08-06 Signal in RSI changed from bearish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-06 Trend Power changed from almost flat to slow.

2023-08-05 Trend pattern changed from расходящийся клин с наклоном вверх to сужающийся канал.

2023-08-05 Trend Power changed from slow to almost flat.

2023-08-04 Signal in MACD changed from bearish reversal to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and it crossed the zero line from the top. These factors mean that there is probably a falling trend. Last signal: down-crossing the middle level.

2023-08-03 Signal in Stochastic changed from bullish to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.


Current temperature: 9.05
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 4
Target Price Mean 60.00
Mean unverified/preliminary 60.00 / 60.00
Target Price Low / High 30.00 / 90.00
Median / STD DEV 60.00 / 27.39
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy Buy
rsi ActivelyBuy ActivelyBuy None
macd None None None
stoch None None None
ma20 None ActivelyBuy Buy
ma50 ActivelyBuy None None
ma100 Buy None None
Candlestick PatternNov. 26, 2025 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US1850632035
ceo Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Website https://clearsidebio.com
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.